Laura Punti B.
- Country
- Spain
- Department
- Medical Oncology
Research Overview
- A Comparative Study of ABP 234 and Pembrolizumab in Patients with Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- Efficacy of LY3537021 plus combination therapy versus placebo for chemotherapy-induced nausea and vomiting in adults with malignant disease
- Phase 3 Evaluation of Zimberelimab and Domvanalimab Versus Pembrolizumab in PD-L1-High Advanced Non-Small Cell Lung Cancer
Data & Insights
Has run more than one trial at 44 of 171 partner sites.
Specializations
Lung Cancer Specialization
The investigator specializes in treating various forms of non-small cell lung cancer (NSCLC), with particular expertise in managing both early-stage and advanced disease states. Their research encompasses Pancoast tumors and RET fusion-positive NSCLC.
- Early-stage NSCLC treatment approaches
- Advanced and metastatic disease management
- Squamous and non-squamous NSCLC variants
The investigator focuses on integrating surgical interventions with systemic therapies for comprehensive treatment strategies.
Immunotherapy Applications
A significant portion of the investigator's work centers on immunotherapeutic approaches in cancer treatment, including the evaluation of novel immunotherapy agents such as avelumab and pembrolizumab.
- Combination immunotherapy strategies
- Post-surgical immunotherapy protocols
- Chemo-immunotherapy combinations
Their expertise extends to studying immune checkpoint inhibitors and their applications in various treatment settings.
Therapeutic Innovation
The investigator is involved in evaluating targeted therapies and novel treatment combinations for cancer management, including research into selpercatinib for specific genetic mutations.
- Second-line therapy development
- Biomarker-driven treatment approaches
- Multimodal treatment strategies
Their work includes investigating treatment outcomes in both adjuvant and metastatic disease settings.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.